Body Contouring in Austin

Overview

What body contouring covers

Body contouring is an umbrella term for treatments aimed at five separate problems: fat, muscle tone, loose skin, cellulite, and the excess skin left after weight loss. No single treatment handles all five, and each one is FDA-cleared or approved for particular uses only. CoolSculpting (FDA 510(k) K233732) and SculpSure (FDA 510(k) K182741) are cleared to break down fat in specific body areas. Emsculpt Neo is cleared to break down abdominal fat and reduce abdominal circumference (FDA 510(k) K192224). Morpheus8 is cleared for procedures in which soft tissue has to be coagulated or contracted (FDA 510(k) K231790). Avéli’s clearance (FDA 510(k) K221336) covers how cellulite looks on the buttocks and thighs of adult women. Surgery is its own path. According to ASPS, a tummy tuck takes out excess skin and fat and, in most cases, also fixes abdominal muscles that have weakened or separated (ASPS).

So open a consultation by saying which of the five bothers you most. That answer shapes your options. ASPS notes, for example, that someone with loose skin or poor tone may not be a good candidate for cryolipolysis (ASPS).

Three newer findings are worth knowing before you book. First, some of the weight people lose on GLP-1 medications is lean mass. In a SURMOUNT-1 substudy, lean mass accounted for about 25% of the weight lost on tirzepatide, the same share seen with placebo (Look et al., Diabetes, Obesity and Metabolism, 2025). Second, published rates of paradoxical adipose hyperplasia after cryolipolysis are now higher than the first estimate (Mah et al., Aesthetic Surgery Journal Open Forum, 2025). Third, the FDA has issued safety communications on Renuvion/J-Plasma (FDA) and on RF microneedling (FDA).

Mechanism

The methods behind non-invasive fat reduction

Each non-invasive fat device relies on cold, on heat, or on heat combined with muscle stimulation.

Cold (cryolipolysis). CoolSculpting Elite chills the treated area to a target temperature as low as -11 °C (FDA 510(k) K233732). The body then clears the damaged fat cells over four to six months (ASPS).

Laser. SculpSure (FDA 510(k) K182741) runs on a 1060 nm laser.

Radiofrequency. truSculpt uses radiofrequency energy to heat tissue. According to its FDA submission, the applicator kept the skin surface between 40 and 45 °C (FDA 510(k) K223110).

Radiofrequency plus muscle stimulation. Emsculpt Neo combines radiofrequency heat with muscle stimulation, and its FDA submission gives a therapy temperature of 40 to 43 °C (FDA 510(k) K192224).

ASPS puts the average fat reduction in a cryolipolysis-treated area at about 20 percent (ASPS). None of these devices is a way to lose weight, and ASPS says none of them replaces liposuction (ASPS). For body areas, the CoolSculpting (FDA 510(k) K233732) and SculpSure (FDA 510(k) K182741) clearances are limited to a BMI of 30 or less.

Fat Devices

Fat reduction devices side by side

CoolSculpting Elite: cryolipolysis

CoolSculpting Elite’s FDA clearance (FDA 510(k) K233732) covers cold-assisted lipolysis at a BMI of 30 or less in the abdomen, flank, thigh, banana roll, back fat, bra fat and upper arm. Under the chin and along the jaw (the submental and submandibular areas), it extends to a BMI of 46.2. Per ASPS, a session takes about an hour, fat drops by about 20 percent on average, and surface irregularities and asymmetry are possible risks (ASPS). ASPS also says people with cryoglobulinemia, cold urticaria or paroxysmal cold hemoglobinuria should not have cryolipolysis (ASPS).

Paradoxical adipose hyperplasia (PAH) means the treated spot develops a firm, enlarged patch of fat when it should have shrunk. Sources disagree on how often it happens:

• First published report: 0.0051% (Jalian et al., JAMA Dermatology, 2014)
• One practice: 0.47% (2 of 422 treatments), which its authors put at 100 times the incidence the manufacturer reported (Singh et al., Lasers in Surgery and Medicine, 2015)
• A Canadian study of 8,658 treatment cycles at 8 centers: 0.05% to 0.39%, with rates falling by more than 75% after newer device models arrived (Nikolis and Enright, Aesthetic Surgery Journal, 2021)
• A pooled analysis of 28 studies and 13,078 patients: 0.22%, with the evidence rated low-certainty (Mah et al., Aesthetic Surgery Journal Open Forum, 2025)
• The manufacturer: about 1 in 3,000 treatments (0.033%) (Allergan Aesthetics)

According to ASPS, men are three times as likely as women to develop PAH, and it is more common in people of Hispanic or Latino descent (ASPS). The 2025 meta-analysis, by contrast, found no statistically significant difference between the sexes (Mah et al., 2025). In the 2014 report, the authors found no evidence that PAH resolves by itself (Jalian et al., 2014). Of 11 patients followed in a 2018 case series, seven had surgery: liposuction for six, and liposuction plus abdominoplasty for one. Surgeons waited for the area to soften, usually 6 to 9 months after cryolipolysis, and three liposuction patients went on to need a second procedure (Kelly et al., Plastic and Reconstructive Surgery, 2018). Ask your provider to explain PAH before you consent.

SculpSure: 1060 nm laser

SculpSure’s clearance (FDA 510(k) K182741) is for non-invasive lipolysis in two settings: the abdomen, flanks, back and thighs at a BMI of 30 or less, and the submental area at a BMI of 49 or less. In a single-arm study, 29 patients had one 25-minute abdominal treatment with a 1060 nm diode laser, and ultrasound showed an 8.55% fat reduction at 12 weeks (Kislevitz et al., Aesthetic Surgery Journal, 2021).

truSculpt: radiofrequency

The clearance for truSculpt (FDA 510(k) K223110) covers non-invasive lipolysis and abdominal circumference reduction, using the 2 MHz setting and the 40 cm² handpiece.

Kybella: deoxycholic acid injection

Kybella is FDA-approved for adults to improve the appearance of moderate to severe fullness caused by fat under the chin (Kybella prescribing information). A single treatment can mean up to 50 small injections, and up to 6 treatments are allowed, spaced at least 1 month apart (Kybella prescribing information). In two placebo-controlled trials, 513 patients received Kybella and 506 received placebo (Kybella prescribing information).

Kybella is approved for the chin area only. According to the label, using it on fat outside the submental region is not approved and not recommended. Serious reactions have been reported after use outside the chin area, including muscle or nerve injury and, near the eyes, blurred or reduced vision (Kybella prescribing information). If a provider suggests Kybella for another part of your body, ask them to explain that choice.

Marginal mandibular nerve injury, which leaves the smile uneven, affected 4% of Kybella patients in the trials. All cases resolved without treatment within 1 to 298 days, with a median of 44 days. Trouble swallowing affected 2% of patients (Kybella prescribing information). Injection-site ulceration, necrosis, nodules, masses and infection are also on the label (Kybella prescribing information).

This site does not publish an Austin price range for any of these treatments.

Muscle

Emsculpt Neo and HIFEM for muscle

Emsculpt Neo’s FDA clearance (FDA 510(k) K192224) is for non-invasive lipolysis and reduction of abdominal circumference. Its clearance study took in 42 people with a BMI of 35 or less. At three months, the study reported that abdominal circumference had shrunk by an average of 3.2 cm, and ultrasound showed fat down by an average of 29.8%. There was a single arm and no control group (FDA 510(k) K192224). The BMI limit of 35 was a study entry criterion and is not part of the cleared indication.

An earlier MRI study looked at the original Emsculpt, which stimulates muscle without adding radiofrequency. In 22 patients measured two months after four treatments, fat thickness fell 18.6%, rectus abdominis thickness rose 15.4% and abdominal muscle separation narrowed 10.4% (Kinney and Lozanova, Lasers in Surgery and Medicine, 2019).

A 2023 systematic review gathered 15 clinical studies on Emsculpt and Emsculpt Neo, and just two of them examined Emsculpt Neo. Across the abdomen, fat thickness dropped 5.5 mm on average, muscle thickness grew 2 mm and muscle separation improved by 3.0 mm. Two studies showed marginal or no benefit, and no study reported a weight change (Kohan et al., Aesthetic Plastic Surgery, 2023).

Skin

Skin tightening and minimally invasive options

Energy devices tighten by heating tissue until it contracts. They cannot cut away skin; that takes surgery, such as a tummy tuck (ASPS).

Morpheus8: fractional radiofrequency microneedling

Morpheus8 delivers radiofrequency energy through a grid of pins that enter the skin. It is cleared for dermatologic procedures requiring soft tissue coagulation or contraction, or hemostasis (FDA 510(k) K231790). On October 15, 2025, the FDA published a safety communication on RF microneedling. The agency says it knows of reports of burns, scarring, fat loss, disfigurement and nerve damage, with some cases needing medical treatment or surgical repair (FDA).

BodyTite: radiofrequency-assisted liposuction

The FDA 510(k) database has no entry under the name BodyTite. Ask the provider which 510(k) number covers the device and what it is cleared to do.

Renuvion / J-Plasma: helium plasma with radiofrequency

In March 2022 the FDA warned against using Renuvion/J-Plasma for dermal resurfacing and skin contraction. At the time, the device had not been determined safe or effective for any aesthetic skin procedure. Narrower clearances followed, and on May 10, 2023 the FDA updated its communication (FDA):

• Renuvion Dermal Handpiece: cleared for moderate to severe wrinkles in people with Fitzpatrick skin types I to III (FDA).
• Renuvion APR Handpiece: cleared to improve lax skin on the neck and below the chin, and to coagulate subcutaneous tissue following liposuction in body contouring (FDA 510(k) K230272).

Ask whether the area you want treated is covered by either clearance.

Cellulite

Options for cellulite

Avéli. This handheld instrument goes in through a small incision to release the fibrous bands (septa) beneath cellulite dimples (FDA 510(k) K221336). The FDA cleared it for long-term reduction in how cellulite looks on the buttocks and thighs of adult women, backed by data showing benefits through one year. In the pivotal study, 74 women had a single treatment. The study met its primary goal, an average improvement greater than 1 point on the Cellulite Severity Scale at 3 months, and results lasted to 6 and 12 months. The most common side effects were bruising in 86.8% of patients, tenderness in 51.5%, pain in 38.2%, firmness in 36.8% and numbness in 17.6% (FDA 510(k) K221336).

truSculpt massage device. Its clearance covers a temporary reduction in how cellulite looks (FDA 510(k) K223110).

Qwo. Endo announced on December 6, 2022 that it would stop making and selling this injectable cellulite treatment, citing concerns about bruising and possible long-lasting skin discoloration (Endo International, SEC filing).

Liposuction does not effectively treat cellulite, according to ASPS (ASPS).

GLP-1

Contouring after weight loss on GLP-1 medications

Weight lost on a GLP-1 medication is partly fat and partly lean mass. A SURMOUNT-1 substudy of 160 participants ran for 72 weeks. Those on tirzepatide lost 21.3% of their body weight, 33.9% of their fat mass and 10.9% of their lean mass. Lean mass made up about 25% of the weight lost, matching the share with placebo (Look et al., Diabetes, Obesity and Metabolism, 2025).

After a large loss, the amount of loose skin left over drives the choice:

• Loose skin or poor tone may make cryolipolysis a poor fit, according to ASPS (ASPS).
• Energy devices such as Morpheus8 have clearance for coagulating or contracting soft tissue (FDA 510(k) K231790), but they cannot remove skin.
• When weight loss leaves skin soft and thin, ASPS says it reshapes less well after liposuction, and more surgery may be needed to remove the extra skin (ASPS).
• A tummy tuck removes excess skin and fat. If you plan further substantial weight loss, ASPS recommends waiting (ASPS).

Before any procedure, tell your provider about any GLP-1 medication you take and ask whether it affects the plan.

Surgical Decision

When to consider surgery

The exam at your consultation decides this. Three factors weigh most: loose skin, muscle separation and weight.

• Liposuction is surgery that removes extra fat from chosen areas. ASPS describes good candidates as people of normal weight who carry some extra fat, and says firm, elastic skin gives better results. It does not treat obesity, and it does not replace diet and exercise (ASPS).
• Tummy tuck (abdominoplasty) removes excess skin and fat and, in most cases, repairs abdominal muscles that are weakened or separated. It leaves stretch marks in place and does not substitute for weight loss. ASPS recommends postponing it if you plan substantial weight loss or a future pregnancy (ASPS).
• Non-surgical fat reduction targets a single fat bulge, and ASPS says none of these treatments is a substitute for liposuction (ASPS).

If surgery is on the table, ask the surgeon about board certification, then check their Texas license on the Texas Medical Board’s Look Up a License page.

What to Expect

What a visit and recovery look like

Consultation. The provider will ask about your health history, including GLP-1 medications, pregnancy or breastfeeding, cold-related conditions if you are considering cryolipolysis, and swallowing or bleeding problems if you are considering Kybella (ASPS) (Kybella prescribing information). They should also pin down whether your concern is fat, muscle, loose skin or cellulite.

Treatment and recovery. The timeline below uses figures published for each treatment. Your provider should give you your own plan and follow-up dates.

1. Day of treatment

   Cryolipolysis: about an hour per treatment, and ASPS lists no activity restrictions afterward (ASPS). Kybella: up to 50 small injections beneath the chin (Kybella prescribing information). Avéli: one treatment, done through a small incision (FDA 510(k) K221336).

2. First weeks

   Some people feel sore after cryolipolysis, much as they would after a workout (ASPS). Swelling, bruising, pain and numbness are common with Kybella (Kybella prescribing information). Within a week of Avéli, 73.5% of study patients had resumed normal activities, and the median bruising duration was 27 days (FDA 510(k) K221336).

3. Months 1–3

   Kybella: any additional treatments are spaced at least 1 month apart (Kybella prescribing information). Emsculpt Neo: in the clearance study, measurements were taken 1, 2 and 3 months after the final treatment (FDA 510(k) K192224). Avéli: the study measured its primary result at 3 months (FDA 510(k) K221336).

4. Months 4–6

   Cryolipolysis: the body clears treated fat cells over four to six months (ASPS). If the area turns firmer and larger when it should be shrinking, ask your provider to check for paradoxical adipose hyperplasia (Jalian et al., 2014).

5. One year

   Avéli: in the pivotal study, results lasted through one year (FDA 510(k) K221336).

Cost

Cost in Austin

This site does not publish an Austin price range for body contouring. Price depends on the device, how many areas you treat and how many sessions you need. Ask for the total in writing, including any packages you must buy, follow-up visits, and the policy on touch-ups and complications.

Combinations

Combining body contouring with other treatments

Treatments are often combined because each one works on a different tissue: fat, muscle or skin. For each treatment in your plan, ask why it is there, when it happens relative to the others, and what it is FDA-cleared for. See also: RF microneedling, dermal fillers, and wellness and HRT.

Texas Law

Choosing a provider in Austin

Texas rules. Delegated non-surgical medical cosmetic procedures fall under 22 TAC Chapter 169, Subchapter E, and the Texas Medical Board’s rule changes took effect January 9, 2025 (Texas Medical Board). Under these rules:

• A physician has to establish a practitioner-patient relationship with you before a delegated procedure, or a PA or APRN can do so under the physician’s delegation. Providers often call this the good faith exam (22 TAC §169.26).
• A physician, PA or APRN must be onsite during the procedure, or immediately available for emergency consultation should an adverse outcome occur (22 TAC §169.26).
• Delegation requires a written order. It names the delegating physician and sets out patient screening criteria, a description of appropriate care, and procedures for complications and emergencies (22 TAC §169.27). The person doing the procedure must also sign and date a written protocol (22 TAC §169.26).
• Every public area and treatment room has to display the name and Texas license number of the delegating physician (22 TAC §169.28).

Questions to ask:

• Who is the delegating physician, and who will do the procedure?
• Is this a genuine device from the manufacturer, and is it a current model? In one multicenter study, PAH rates fell by more than 75% once newer CoolSculpting models came out (Nikolis and Enright, 2021).
• Is the area I want treated within the device’s FDA-cleared use?
• For CoolSculpting: how do you explain the PAH risk, and how do you treat PAH if it happens?
• How much fat reduction can I expect, and how will you measure it? For cryolipolysis, ASPS reports an average of about 20 percent (ASPS).
• What is the total cost, and what is your approach to revisions and complications?

Where to check licenses:

• Physician license: the Texas Medical Board’s Look Up a License page
• Registered nurse license: Texas Board of Nursing license verification

Areas

Areas and the devices cleared for them

• Abdomen and flanks: CoolSculpting (FDA 510(k) K233732) and SculpSure (FDA 510(k) K182741). For the abdomen only: Emsculpt Neo (FDA 510(k) K192224) and truSculpt (FDA 510(k) K223110).
• Thighs and banana roll: CoolSculpting for the thigh and banana roll (FDA 510(k) K233732), and SculpSure for the thighs (FDA 510(k) K182741).
• Upper arms: CoolSculpting is cleared here (FDA 510(k) K233732).
• Bra fat and back: CoolSculpting for bra fat and back fat (FDA 510(k) K233732), and SculpSure for the back (FDA 510(k) K182741).
• Under the chin: Kybella (Kybella prescribing information); CoolSculpting (FDA 510(k) K233732) and SculpSure (FDA 510(k) K182741) for chin fat; and Renuvion APR for lax skin (FDA 510(k) K230272).
• Buttocks and thighs (cellulite): Avéli is cleared for this (FDA 510(k) K221336).